Bloomberg
Wealth
|
Icahn Hit by Hindenburg Short as Activist Becomes Target
|
watch
|
|
WATCH: Shares in billionaire Carl Icahn’s
investment firm plunged 20% in a record one day drop after
a negative report by short seller Hindenburg Research.
Source: Bloomberg
|
By Breanna
Bradham
May 2, 2023 at 8:44 AM EDT Updated
on May 2, 2023 at 4:29 PM ED
Carl Icahn, the famed activist investor who’s made a career out of
starting corporate brawls, found himself on the receiving end of
criticism Tuesday after Hindenburg
Research disclosed a short call against his
investment firm.
Shares of Icahn
Enterprises LP closed down 20% in the biggest
one-day drop on record, after Hindenburg claimed in a lengthy report
that the company is overpriced, and said it found evidence of inflated
valuations for some of its assets.
Icahn hit back at Hindenburg hours after the report came out, saying
that the firm’s performance would “speak for itself over the long term
as it always has.”
“We stand by our public disclosures,” Icahn said in a statement.
“We believe strongly in hedging our positions to mitigate risk,
especially in markets that we are living in today,” Icahn added.
“We think Icahn, a legend of Wall Street, has made a classic mistake
of taking on too much leverage in the face of sustained losses: a
combination that rarely ends well,” Hindenburg said in the report.
The missive pits Icahn, 87, against Hindenburg’s founder Nathan
Anderson, who has made a name for his research firm in recent years by targeting corporate
giants like payments company Block Inc. and billionaire Gautam Adani’s
business empire.
In Tuesday’s report, Hindenburg claimed Icahn Enterprises’ value is
inflated by 75% or more, noting that it trades at a premium of more
than 200% to its net asset value. Other closed-end holding companies
like Dan Loeb’s Third Point and Bill Ackman’s Pershing Square trade at
discounts to their NAV, according to Hindenburg.
The report also raises questions about the size of Icahn Enterprises’
dividend yield and the way in which it has been financed in recent
years.
“Icahn has been using money taken in from new investors to pay out
dividends to old investors,” Hindenburg said in the report. “Such
Ponzi-like economic structures are sustainable only to the extent that
new money is willing to risk being the last one ‘holding the bag.’”
Carl Icahn in 2015 Photographer:
Victor J. Blue/
|
Hindenburg’s report also singled out Jefferies
Financial Group Inc., which it said is the only large
investment bank that publishes research coverage on Icahn Enterprises.
Jefferies analyst Daniel Fannon currently has a ‘buy’ rating on the
stock, with a target price of $70.
“Jefferies’ research assumes in all cases, even in its bear case, that
IEP’s dividend will be safe ‘into perpetuity’, despite providing no
support for that assumption,” Hindenburg wrote. Representatives for
Jefferies didn’t have an immediate comment.
While Hindenburg has been active since 2018, when Anderson incorporated
the company from an apartment in New York,
Icahn has been stalking the corporate world for around 50 years. He
wrote Tuesday that Icahn Enterprises continues “to believe that
activism is the best paradigm for investing.”
A decade ago, he and activist hedge-fund manager Bill Ackman went to
war over Herbalife
Ltd., with Ackman calling the nutritional-supplements
company’s model a pyramid scheme and going public with a $1 billion
short bet. Icahn, who at one point owned almost a quarter of
Herbalife’s shares, defended the multilevel-marketing model and
publicly assailed Ackman for years — on stages and television, in
documentaries and online — after an initial CNBC phone-in argument
between the two billionaires.
Ackman weighed in on the Hindenburg report via Twitter on Tuesday,
calling it a “must read.”
In 2015, a debate at a Delivering Alpha conference between Icahn and BlackRock
Inc. Chief Executive Officer Larry Fink
quickly devolved into a verbal
slugfest. Icahn called an open letter by Fink, which argued
that corporate CEOs shouldn’t repurchase shares just to satisfy
activists, a “sales
pitch for BlackRock” and called the firm “an
extremely dangerous company” over its exchange-traded funds.
More recently, Icahn has battled with DNA-sequencing company Illumina
Inc., saying the board of the company set a “new low” in governance by
pursuing its acquisition of Grail Inc. over antitrust regulators’
objections. In a meeting with Illumina CEO Francis deSouza and
Chairman John Thompson in early March, Icahn was quoted
as saying he “would not even support Jesus
Christ” as an independent candidate over his board nominees who
“answer to me.”
Icahn said later that month that Illumina had “taken out of context
certain things that were supposedly said” during discussions meant to
be private “in the hopes of achieving peace rather than war.”
On average, companies
targeted by Hindenburg fell about 15% the day
after a negative report appeared and were down 26% six months later,
according to February calculations by Bloomberg News.
— With assistance by Katherine Burton
(Updates
chart, shares throughout to reflect market close.)
©2023 Bloomberg L.P. All Rights Reserved
|